NYSE · Medical - Instruments & Supplies

TFX (TFX) Stock

$136.71 +3.33% NYSE: TFX Healthcare

Valuation

MetricValue
Price$136.71
Market Cap$6.05B
P/E Ratio1866.00
P/B Ratio1.87
P/S Ratio2.06
EPS (TTM)$-20.25
52-Week High$139.67
52-Week Low$100.18
Dividend Yield1.04%

Financials & Margins

MetricValue
ROE0.04%
ROA2.33%
ROCE8.19%
Gross Margin53.27%
Operating Margin6.48%
Net Margin-35.89%
Debt/Equity0.06
Current Ratio2.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.8B$2.8B$3.0B$3.0B$2.0B
Operating Profit$628.0M$500.0M$506.0M$151.0M$256.0M
Net Profit$485.0M$363.0M$356.0M$70.0M$-906.0M
EPS$10.23$7.68$7.53$1.48$-20.25
Op Margin22.4%17.9%17.0%5.0%12.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.9B$6.9B$7.5B$7.1B$6.9B
Total Liabilities$3.1B$2.9B$3.1B$2.8B$3.8B
Cash$445.0M$292.0M$223.0M$290.0M$393.0M
Borrowings$2.0B$1.8B$1.9B$1.8B$2.7B

Latest News

TFX: Raising target price to $142.00 Argus Research · Jul 22, 2026 Teleflex Signs Central Venous Access Deal With Premier MT Newswires · Jul 21, 2026 Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. Business Wire · Jul 21, 2026 BMO Captal Initiates Coverage on Teleflex With Outperform Rating, $159 Price Target MT Newswires · Jul 9, 2026 Teleflex Publishes 2025 Global Impact Report Business Wire · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$651.0M$342.0M$511.0M$636.0M$341.0M
Investing Cash Flow$85.0M$-337.0M$-713.0M$-226.0M$-944.0M
Financing Cash Flow$-29.0M$-13.0M$1.0M$-197.0M$-310.0M
Net Cash Flow$69.0M$-153.0M$-69.0M$105.0M$74.0M
Free Cash Flow$580.0M$263.0M$419.0M$509.0M$245.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.16
EV / EBITDA18.07
FCF Yield4.31%
Quick Ratio2.03
Interest Coverage2.56
Return 1Y24.38%
Return 3Y-46.45%
Return 5Y-64.40%

Ownership

Insiders Held0.47%
Institutions Held109.30%
Institutions Float Held109.82%
Institutional HolderSharesReport Date
Blackrock Inc.5,391,9912026-03-31
Janus Henderson Group PLC4,291,3112026-03-31
T. Rowe Price Investment Management, Inc.3,836,2072026-03-31
Vanguard Portfolio Management LLC2,438,1832026-03-31
Vanguard Capital Management LLC1,983,8242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALKS $50.71 -3.84% 25.87 $8.45B 0.00%
ARWR $86.01 +1.61% -7397.00 $12.12B 0.00%
BLCO $16.76 +0.48% 13.97 $5.99B 0.00%
CRSP $46.73 +0.41% -12.98 $4.51B 0.00%
KRYS $312.57 -8.37% 42.90 $9.21B 0.00%

About TFX

TFX stock trades at $136.71 with a market capitalization of $6.05B. The stock is valued at a price-to-earnings (P/E) ratio of 1866.00, price-to-book of 1.87, price-to-sales of 2.06. Over the past 52 weeks the stock has ranged between $100.18 and $139.67, and currently trades 2.1% below its 52-week high. It pays a dividend yielding 1.04%.

On profitability, TFX generates a return on equity (ROE) of 0.04%, return on capital employed of 8.19%, an operating margin of 6.48%, a net profit margin of -35.89%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides